Executive Message

Greater Pharma Group is committed to becoming a leading ASEAN healthcare innovator, driving advancements in health and beauty solutions. Our mission began with a clear intention — to develop high-quality products that address the health concerns of Thai people, ensuring accessibility at a fair price. This goal not only reduces dependence on imported products, but also enables sustainable profitability for our business partners. Research, development, and the advancement of locally-driven innovation have become the foundation of our vision and the engine that propels our organization forward.

We have continued to expand our work through collaborative research and development with leading universities across Thailand to strengthen the competitiveness of the pharmaceutical industry and create innovative health products for the nation. One key milestone includes the development of cockroach-allergy vaccines, among several others, in collaboration with the Faculty of Medicine Siriraj Hospital — building on our success with house dust mite allergy vaccines and allergy test kits. Today, Greater Pharma proudly stands as the first and only manufacturer in ASEAN to produce all ten allergy vaccines commercially.

Furthermore, we aim to be the first manufacturer in ASEAN to conduct research and development within the field of Advanced Therapy Medicinal Products (ATMP), including stem cell and NK cell technology. These innovations represent new treatment pathways for cancer and other severe diseases. Our progress in this field has been reinforced by official approval from the Thai Food and Drug Administration (FDA), granting us the license to produce these advanced therapies.

Greater Pharma will continue to uphold our mission and vision — to drive scientific development both within the company and through national research partnerships. We remain dedicated to creating innovative healthcare solutions that meet evolving consumer needs in an era of disruptive technology, while moving steadily toward our goal of becoming a long-term innovation leader in ASEAN’s healthcare sector.

Executive Message

Greater Pharma Group is committed to becoming a leading ASEAN healthcare innovator, driving advancements in health and beauty solutions. Our mission began with a clear intention — to develop high-quality products that address the health concerns of Thai people, ensuring accessibility at a fair price. This goal not only reduces dependence on imported products, but also enables sustainable profitability for our business partners. Research, development, and the advancement of locally-driven innovation have become the foundation of our vision and the engine that propels our organization forward.

We have continued to expand our work through collaborative research and development with leading universities across Thailand to strengthen the competitiveness of the pharmaceutical industry and create innovative health products for the nation. One key milestone includes the development of cockroach-allergy vaccines, among several others, in collaboration with the Faculty of Medicine Siriraj Hospital — building on our success with house dust mite allergy vaccines and allergy test kits. Today, Greater Pharma proudly stands as the first and only manufacturer in ASEAN to produce all ten allergy vaccines commercially.

Furthermore, we aim to be the first manufacturer in ASEAN to conduct research and development within the field of Advanced Therapy Medicinal Products (ATMP), including stem cell and NK cell technology. These innovations represent new treatment pathways for cancer and other severe diseases. Our progress in this field has been reinforced by official approval from the Thai Food and Drug Administration (FDA), granting us the license to produce these advanced therapies.

Greater Pharma will continue to uphold our mission and vision — to drive scientific development both within the company and through national research partnerships. We remain dedicated to creating innovative healthcare solutions that meet evolving consumer needs in an era of disruptive technology, while moving steadily toward our goal of becoming a long-term innovation leader in ASEAN’s healthcare sector.

Greater Pharma Group of Company

Innovation & Awards

Researched and developed by the Department of Pharmacy and Natural Products, Thailand Institute of Scientific and Technological Research (TISTR).

SCL is the only company certified and licensed by the Thai FDA (Food and Drug Administration).

Innovative antibacterial face mask coated with mangosteen peel extract, proven to filter up to 98% of bacteria.

The first and only manufacturer in Thailand certified with ISO specifically for “Manufacturing of Stem Cells.”

PROBIOTICS (Probiotic Supplements)

Researched and developed by the Pharmacy & Natural Product Division, TISTR (repeated statement unified for clarity).

A proprietary innovation developed through collaborative research between Greater Pharma and Chulalongkorn University.

Our laboratory operates under a Negative Pressure System, ensuring the highest level of contamination control and infection prevention

Greater Pharma – A Leader in Sustainable Healthcare for Thailand and Beyond

Greater Pharma Co., Ltd. is committed to becoming a sustainable healthcare leader in Thailand. With a vision to ensure that every Thai citizen has access to high-quality healthcare products at attainable prices, we continue to invest in research, development, and manufacturing excellence without compromise.

As a key contributor to the healthcare industry, our product portfolio spans a wide spectrum — from high-quality generic medicines and over-the-counter pharmaceutical products, to dietary supplements, cosmetics, and advanced technology–based innovations. Every step of our production process is governed by internationally recognized standards, including ISO 9001:2008, GMP, and ISO/IEC 17025, assuring precision, quality, and safety at the highest level.

We consistently drive innovation, elevating product standards to compete globally and exceed expectations. Our mission is to deliver the very best to the people of Thailand while expanding our presence to the international market — building a healthier future for generations to come.

Innovation & Awards

Researched and developed by the Department of Pharmacy and Natural Products, Thailand Institute of Scientific and Technological Research (TISTR).

SCL is the only company certified and licensed by the Thai FDA (Food and Drug Administration).

Innovative antibacterial face mask coated with mangosteen peel extract, proven to filter up to 98% of bacteria.

The first and only manufacturer in Thailand certified with ISO specifically for “Manufacturing of Stem Cells.”

PROBIOTICS (Probiotic Supplements)

Researched and developed by the Pharmacy & Natural Product Division, TISTR (repeated statement unified for clarity).

A proprietary innovation developed through collaborative research between Greater Pharma and Chulalongkorn University.

Our laboratory operates under a Negative Pressure System, ensuring the highest level of contamination control and infection prevention

Greater Pharma – A Leader in Sustainable Healthcare for Thailand and Beyond

Greater Pharma Co., Ltd. is committed to becoming a sustainable healthcare leader in Thailand. With a vision to ensure that every Thai citizen has access to high-quality healthcare products at attainable prices, we continue to invest in research, development, and manufacturing excellence without compromise.

As a key contributor to the healthcare industry, our product portfolio spans a wide spectrum — from high-quality generic medicines and over-the-counter pharmaceutical products, to dietary supplements, cosmetics, and advanced technology–based innovations. Every step of our production process is governed by internationally recognized standards, including ISO 9001:2008, GMP, and ISO/IEC 17025, assuring precision, quality, and safety at the highest level.

We consistently drive innovation, elevating product standards to compete globally and exceed expectations. Our mission is to deliver the very best to the people of Thailand while expanding our presence to the international market — building a healthier future for generations to come.